Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1555, 2006-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CV disorder risks extend beyond COX-2-selectivity of NSAIDs
Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. :
NSAID-related CV risks not defined by COX-2 selectivity alone
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :
COX-2 inhibitors: increased risk of CV events?
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Is the Use of Selective COX Inhibitors Associated with an Increased Risk of Cardiovascular Events?
Heart Drug, Vol. 4, Iss. 2, 2004-05 ,pp. :